Pennsylvania: GSK will create at least 200 new, high-paying jobs in Lancaster County
Reading time 1 min Christian Fernsby ▼ | October 25, 2024Governor Josh Shapiro and GSK leadership announced the global biopharma company’s major investment of up to $800 million in Pennsylvania that will increase its research and development (R&D) and manufacturing footprint at its existing facility in Lancaster County.
Pennsylvania GSK
This is the largest Commonwealth-supported economic development project in Lancaster County history.
GSK will expand its existing facility at 325 North Bridge Street in Marietta with new facilities to manufacture vaccines and medicines.
Currently, one in four Americans are administered a vaccine supplied from the company’s Marietta location. This expansion will double the size and capacity of the site.
In addition to the expansion, GSK will retain at least 4,622 jobs statewide and keep its U.S. headquarters in Philadelphia. ■